X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DR. DATSONS LABS - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DR. DATSONS LABS PFIZER/
DR. DATSONS LABS
 
P/E (TTM) x 36.2 -10.9 - View Chart
P/BV x 5.3 0.2 3,280.3% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 PFIZER   DR. DATSONS LABS
EQUITY SHARE DATA
    PFIZER
Mar-18
DR. DATSONS LABS
Mar-14
PFIZER/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs2,365126 1,883.0%   
Low Rs1,62531 5,258.9%   
Sales per share (Unadj.) Rs430.3133.0 323.5%  
Earnings per share (Unadj.) Rs78.70.2 51,911.7%  
Cash flow per share (Unadj.) Rs93.26.6 1,410.2%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.5128.8 455.4%  
Shares outstanding (eoy) m45.7531.66 144.5%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x4.60.6 788.0%   
Avg P/E ratio x25.3516.1 4.9%  
P/CF ratio (eoy) x21.411.8 180.8%  
Price / Book Value ratio x3.40.6 559.9%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,2712,477 3,684.2%   
No. of employees `0002.6NA-   
Total wages/salary Rs m3,14356 5,612.3%   
Avg. sales/employee Rs Th7,484.8NM-  
Avg. wages/employee Rs Th1,195.0NM-  
Avg. net profit/employee Rs Th1,369.1NM-  
INCOME DATA
Net Sales Rs m19,6854,211 467.5%  
Other income Rs m1,14379 1,452.2%   
Total revenues Rs m20,8284,289 485.6%   
Gross profit Rs m5,003569 879.9%  
Depreciation Rs m663204 324.1%   
Interest Rs m4430 1.0%   
Profit before tax Rs m5,47913 43,142.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,8786 30,793.4%   
Profit after tax Rs m3,6015 75,014.6%  
Gross profit margin %25.413.5 188.2%  
Effective tax rate %34.348.0 71.4%   
Net profit margin %18.30.1 16,045.1%  
BALANCE SHEET DATA
Current assets Rs m24,1676,852 352.7%   
Current liabilities Rs m9,5446,711 142.2%   
Net working cap to sales %74.33.3 2,218.2%  
Current ratio x2.51.0 248.0%  
Inventory Days Days55161 34.2%  
Debtors Days Days29318 9.0%  
Net fixed assets Rs m9,5143,673 259.0%   
Share capital Rs m458317 144.5%   
"Free" reserves Rs m26,3753,761 701.3%   
Net worth Rs m26,8324,078 658.1%   
Long term debt Rs m251,671 1.5%   
Total assets Rs m36,90012,633 292.1%  
Interest coverage x1,305.51.0 126,811.2%   
Debt to equity ratio x00.4 0.2%  
Sales to assets ratio x0.50.3 160.1%   
Return on assets %9.83.4 283.7%  
Return on equity %13.40.1 11,399.5%  
Return on capital %20.47.7 266.1%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m22964 2.3%   
Fx outflow Rs m1,489607 245.2%   
Net fx Rs m-1,466357 -410.8%   
CASH FLOW
From Operations Rs m3,3181,345 246.7%  
From Investments Rs m-2,383-2,256 105.6%  
From Financial Activity Rs m-1,104-1,200 92.0%  
Net Cashflow Rs m-169-2,111 8.0%  

Share Holding

Indian Promoters % 0.0 4.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 4.9 1.4 363.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 94.1 25.2%  
Shareholders   85,207 20,807 409.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  NOVARTIS  J.B.CHEMICALS  MERCK LTD  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Stock Market's Sudden Crash; Rising Oil Prices; Banking Stocks and Top Cues in Action Today(Pre-Open)

The Indian share markets ended lower on Friday. The S&P BSE Sensex partially recovered after crashing 1,000 points in intraday trade to settle 280 points lower.

Related Views on News

PFIZER Announces Quarterly Results (1QFY19); Net Profit Up 60.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, PFIZER has posted a net profit of Rs 918 m (up 60.6% YoY). Sales on the other hand came in at Rs 5 bn (up 18.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY18); Net Profit Up 53.6% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, PFIZER has posted a net profit of Rs 1 bn (up 53.6% YoY). Sales on the other hand came in at Rs 5 bn (up 14.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 24, 2018 09:23 AM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS